Glucose Com Cloreto De Sódio Basi

Glucose Com Cloreto De Sódio Basi is an intravenous injection solution that combines sodium chloride and glucose. The product is supplied in a sterile liquid form intended for infusion into the bloodstream. It is manufactured for the European market and is classified as an IV electrolyte and carbohydrate solution used to restore fluid volume, correct electrolyte disturbances, and provide metabolic energy.

Glucose Com Cloreto De Sódio Basi is indicated for several clinical situations where fluid and electrolyte balance must be rapidly corrected. It is commonly employed in hospital settings for patients who cannot maintain adequate oral intake.

- Replacement of extracellular fluid loss due to surgery, trauma, or burns. - Correction of hyponatremia or other electrolyte imbalances. - Prevention or treatment of hypoglycemia in patients unable to eat. - Support of metabolic needs during critical care or anesthesia. - Maintenance of hydration in patients receiving parenteral nutrition.

Adverse reactions to Glucose Com Cloreto De Sódio Basi are generally infrequent but can vary in severity.

Common: - Mild infusion site irritation or pain. - Transient hyperglycemia. - Slight increase in serum sodium levels. - Nausea or mild vomiting. - Headache. - Low-grade fever.

Serious: - Severe hypernatremia. - Acute hyperglycemic crisis. - Allergic reaction with rash, itching, or bronchospasm. - Fluid overload leading to pulmonary edema. - Electrolyte disturbances such as hyperchloremia. - Hemolysis from rapid infusion.

When using Glucose Com Cloreto De Sódio Basi, clinicians should observe several safety measures to minimize risk.

- Verify patient’s electrolyte status and glucose level before administration. - Adjust infusion rate in patients with cardiac or renal insufficiency to avoid fluid overload. - Use caution in neonates and elderly patients due to altered fluid distribution. - Monitor serum sodium and glucose frequently during therapy. - Avoid rapid bolus administration; infuse over the recommended time. - Store the solution according to manufacturer guidelines to maintain sterility.

Glucose Com Cloreto De Sódio Basi may interact with other medications administered intravenously.

Avoid: - Concurrent infusion of hypertonic saline solutions that could exacerbate hypernatremia. - Co‑administration with high‑dose insulin without glucose monitoring, risking severe hypoglycemia.

Use with caution: - Loop diuretics, which may increase sodium loss and require electrolyte monitoring. - Corticosteroids, which can raise blood glucose levels. - Vasopressors, where fluid volume changes may affect blood pressure control. - Other carbohydrate-containing IV solutions, to prevent excessive glucose load. - Medications that affect renal function, as they may alter electrolyte handling.